REVIEW

BEST PRACTICE NO 184

BEST PRACTICE NO 184 Screening for thyroid disease in pregnancy

J H Lazarus and L D K E Premawardhana

Centre for Endocrine and Diabetes Sciences, Cardiff University, Cardiff CF14 4XN, Wales, UK

Correspondence to:
Correspondence to:
Professor J H Lazarus
Department of Medicine, Llandough Hospital, Cardiff CF64 2XX, UK; Lazarus{at}cf.ac.uk

Although gestational hyperthyroidism is uncommon (0.2%), hypothyroidism (autoimmune disease or suboptimal iodine intake) occurs in 2.5% of women and is predictive of reduced neonatal and child neuropsychological development and maternal obstetric complications. Postpartum thyroid dysfunction (PPTD) occurs in 5–9% of women and is associated with antithyroid peroxidase antibodies (antiTPOAb) in 10% of women in early pregnancy. Therefore, screening for thyroid dysfunction in pregnancy should be considered. T4 and thyroid stimulating hormone measurements could be used to screen for hypothyroidism, which would require levothyroxine intervention treatment. T4 supply is crucial to fetal nervous system maturation; currently, the recommended daily iodine intake is 200 µg, and this is not always achieved, even in the UK. At present, a randomised prospective trial is ongoing to provide the evidence base for this screening strategy. Meanwhile, it is reasonable to (a) optimise iodine nutrition during pregnancy; (b) ascertain women with known thyroid disease; (c) identify women at increased risk of thyroid disease—for example, those with other autoimmune diseases. PPTD can be predicted by measurement of antiTPOAb in early gestation.

Abbreviations: antiTPOAb, antithyroid peroxidase antibody; FT4, free T4; PPTD, postpartum thyroid dysfunction; TSH, thyroid stimulating hormone; TSHRAb, thyroid stimulating hormone receptor stimulating antibodies

Keywords: screening; thyroid; pregnancy; postpartum

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Springer, D., Zima, T., Limanova, Z. (2009). Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol 160: 791-797 [Abstract] [Full Text]  
• Moleti, M., Lo Presti, V. P., Mattina, F., Mancuso, A., De Vivo, A., Giorgianni, G., Di Bella, B., Trimarchi, F., Vermiglio, F. (2009). Gestational thyroid function abnormalities in conditions of mild iodine deficiency: early screening versus continuous monitoring of maternal thyroid status. Eur J Endocrinol 160: 611-617 [Abstract] [Full Text]  
• (2007). Subsection Reports. J. Clin. Endocrinol. Metab. 92: s8-s47 [Full Text]  
• Abalovich, M., Amino, N., Barbour, L. A., Cobin, R. H., De Groot, L. J., Glinoer, D., Mandel, S. J., Stagnaro-Green, A. (2007). Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 92: s1-s47 [Abstract] [Full Text]  
• Premawardhana, L D K E, Lazarus, J H (2006). Management of thyroid disorders.. Postgrad. Med. J. 82: 552-558 [Abstract] [Full Text]